Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 6
Submit an article Journal homepage
435
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

The propriety of upgrading responses to venetoclax + azacitidine in newly diagnosed patients with acute myeloid leukemia

Diana Abbotta Department of Public Health, University of Colorado, Aurora, CO, USA
,
Evan Cherryb Department of Medicine, Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USA
,
Maria Amayab Department of Medicine, Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USA
,
Christine McMahonb Department of Medicine, Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USA
,
Marc Schwartzb Department of Medicine, Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USA
,
Amanda Wintersb Department of Medicine, Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USA
,
Jeffrey Schowinskyb Department of Medicine, Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USA
,
Craig T. Jordanb Department of Medicine, Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USA
,
Clayton Smithb Department of Medicine, Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USA
,
Jonathan A. Gutmanb Department of Medicine, Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USA
&
Daniel A. Pollyeab Department of Medicine, Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USACorrespondence[email protected]
 show all
Pages 1466-1473 | Received 03 Dec 2020, Accepted 04 Dec 2020, Published online: 30 Dec 2020

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jan Philipp Bewersdorf, Rory M. Shallis, Andriy Derkach, Aaron D. Goldberg, Anthony Stein, Eytan M. Stein, Guido Marcucci, Amer M. Zeidan, Shai Shimony, Daniel J. DeAngelo, Richard M. Stone, Ibrahim Aldoss, Brian J. Ball & Maximilian Stahl. (2023) Venetoclax-based salvage therapy in patients with relapsed/refractory acute myeloid leukemia previously treated with FLT3 or IDH1/2 inhibitors. Leukemia & Lymphoma 64:1, pages 188-196.
Read now

Articles from other publishers (4)

Romeo G. Mihăilă. (2023) Venetoclax in Acute Myeloid Leukemia. Recent Patents on Anti-Cancer Drug Discovery 18:1, pages 11-28.
Crossref
Nazmul Islam, Jamie S. Reuben, Justin Dale, Jon Gutman, Christine M. McMahon, Maria Amaya, Bruce Goodman, Joseph Toninato, Maura Gasparetto, Brett Stevens, Shanshan Pei, Austin Gillen, Sarah Staggs, Krysta Engel, Sarah Davis, Madelyne Hull, Elizabeth Burke, Lenny Larchick, Richard Zane, Grant Weller, Craig Jordan & Clay Smith. (2022) Machine Learning–Based Exploratory Clinical Decision Support for Newly Diagnosed Patients With Acute Myeloid Leukemia Treated With 7 + 3 Type Chemotherapy or Venetoclax/Azacitidine. JCO Clinical Cancer Informatics:6.
Crossref
Sabine Kayser & Mark J. Levis. (2021) Updates on targeted therapies for acute myeloid leukaemia. British Journal of Haematology 196:2, pages 316-328.
Crossref
Evan M. Cherry, Diana Abbott, Maria Amaya, Christine McMahonMarc SchwartzJulie Rosser, Audrey Sato, Jeffrey Schowinsky, Anagha InguvaMohd MinhajuddinShanshan PeiBrett StevensAmanda Winters, Craig T. JordanClayton SmithJonathan A. GutmanDaniel A. Pollyea. (2021) Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia. Blood Advances 5:24, pages 5565-5573.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.